May 13, 2025
2:00 PM - 3:00 PM (your local time)
Join us to learn how BIOVIA and CCDC help unlock innovation through virtual screening and data analysis for small molecule therapeutics design on 3DEXPERIENCE® platform.
Successful drug discovery is founded on “in-silico first” approaches, such as GOLD for virtual screening and predicting protein-ligand interactions. In combination, recent advancements in cloud computing offer unprecedented flexibility and scalability to power such solutions.
Using the collaborative 3DEXPERIENCE® cloud platform, Dassault Systèmes BIOVIA and Cambridge Crystallographic Data Center (CCDC) present GOLD's advanced algorithms for accurate and efficient virtual screening, lead optimization, and structure-based drug design to unlock innovation for small molecule therapeutics discovery.
Webinar Highlights:
Register now to secure your spot!